Cargando…

Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study

A prospective randomized phase II trial was conducted to evaluate the time course effects of toremifene (TOR) and letrozole (LET), as adjuvant hormone therapy, on serum lipid profiles and bone metabolism in estrogen receptor (ER)-positive, postmenopausal breast cancer patients.Fifty-four postmenopau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shien, Tadahiko, Doihara, Hiroyoshi, Sato, Nobuaki, Anan, Keisei, Komaki, Kansei, Miyauchi, Keisuke, Yanagita, Yasuhiro, Fujisawa, Tomomi, Mitsuyama, Shoshu, Kanbayashi, Chizuko, Kusama, Mikihiro, Kimura, Morihiko, Jinno, Hiromitsu, Sano, Muneaki, Ikeda, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778152/ https://www.ncbi.nlm.nih.gov/pubmed/29196963 http://dx.doi.org/10.1007/s00280-017-3491-6

Ejemplares similares

Ductal carcinoma in situ arising in tubular adenoma of the breast
por: Saimura, Michiyo, et al.
Publicado: (2012)

Fertility preservation in breast cancer patients
por: Shien, Tadahiko, et al.
Publicado: (2013)

Effect of local surgery on outcomes of stage IV breast cancer
por: Tsukioki, Takahiro, et al.
Publicado: (2020)

Comparative effectiveness of tamoxifen, toremifene, letrozole, anastrozole, and exemestane on lipid profiles in breast cancer patients: A network meta-analysis
por: He, Tao, et al.
Publicado: (2020)

Anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the breast: a case report and review of the literature
por: Kawakita, Yasutaka, et al.
Publicado: (2023)

Toremifene interacts with and destabilizes the Ebola virus glycoprotein
por: Zhao, Yuguang, et al.
Publicado: (2016)

A Radial Sclerosing Lesion Mimicking Breast Cancer on Mammography in a Young Woman
por: Furukawa, Masashi, et al.
Publicado: (2012)

Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene
por: Balducci, Chiara, et al.
Publicado: (2005)

Multiple angiosarcomas of both breasts: a case report
por: Matsuda, Ryota, et al.
Publicado: (2023)

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
por: Sasada, Shinsuke, et al.
Publicado: (2023)

A case of primary extraskeletal osteosarcoma of the breast
por: Kurata, Kanako, et al.
Publicado: (2018)

A Case of Carcinoma Showing Thymus-Like Differentiation with a Rapidly Lethal Course
por: Nogami, Tomohiro, et al.
Publicado: (2014)

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples
por: Iwamoto, Takayuki, et al.
Publicado: (2019)

Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women
por: Marttunen, M B, et al.
Publicado: (2001)

Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer
por: Song, Dandan, et al.
Publicado: (2021)

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells
por: Ikeda, Hirokuni, et al.
Publicado: (2010)

Breast Cancer Metastasis to the Stomach That Was Diagnosed after Endoscopic Submucosal Dissection
por: Kita, Masahide, et al.
Publicado: (2016)

High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases
por: Mori, Ryutaro, et al.
Publicado: (2014)

Circumvention of Daunorubicin Resistance by a New Tamoxifen Derivative, Toremifene, in Multidrug‐resistant Cell Line
por: Urasaki, Yoshimasa, et al.
Publicado: (1994)

A Multicenter Study of Docetaxel at a Dose of 100 mg/m(2) in Japanese Patients with Advanced or Recurrent Breast Cancer
por: Hirata, Taizo, et al.
Publicado: (2020)

K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene
por: Hachisuga, T, et al.
Publicado: (2005)

Influences of preoperative metformin on immunological factors in early breast cancer
por: Tsukioki, Takahiro, et al.
Publicado: (2020)

Current approach and future perspective for ductal carcinoma in situ of the breast
por: Kanbayashi, Chizuko, et al.
Publicado: (2017)

DNA methylation status of REIC/Dkk-3 gene in human malignancies
por: Hayashi, Tatsuro, et al.
Publicado: (2012)

Inhibitory Effects of Toremifene on N‐Methyl‐N‐nitrosourea and Estradiol‐17β‐induced Endometrial Carcinogenesis in Mice
por: Niwa, Kenji, et al.
Publicado: (2002)

A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis
por: Hong, Jin, et al.
Publicado: (2020)

Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers
por: Iwamoto, Takayuki, et al.
Publicado: (2017)

A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
por: Aphinives, Potchavit, et al.
Publicado: (2015)

Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case–control study in Japanese women
por: Mizoo, Taeko, et al.
Publicado: (2013)

Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report
por: Suzuki, Yoko, et al.
Publicado: (2020)

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
por: PyrhÃ¶nen, S., et al.
Publicado: (1997)

High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors
por: Fushimi, Atsushi, et al.
Publicado: (2020)

The early days of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2007)

The early days of letrozole
por: Bhatnagar, Ajay S.
Publicado: (2008)

Letrozole for Female Infertility
por: Yang, Ai-Min, et al.
Publicado: (2021)

Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study
por: Tanaka, Kiyo, et al.
Publicado: (2021)

YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development
por: Fujihara, Miwa, et al.
Publicado: (2021)

Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen
por: Wang, Hongyue, et al.
Publicado: (2021)

Impact of breast surgery in de novo stage IV breast cancer
por: Shien, Tadahiko
Publicado: (2019)

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer
por: Miyoshi, Yuichiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s62d8e0tgq0l74n8b235rl5cl4